Site menu:

Sponsors:

Astra Zeneca

Media Partners:

PharmCast

PPXRD-8

The 8th Pharmaceutical Powder X-ray Diffraction Symposium
Sponsored by the International Centre for Diffraction Data
4-7 May 2009
Glasgow, Scotland, U.K.

Call for Papers

PPXRD-8 Program Topics
4-7 May 2009

Optional Workshop
Characterization of Pharmaceutical Solids
Monday, 4 May
 9.00-17.00

Workshop instructors are scientists from academia, industry and the International Centre for Diffraction Data. In order to facilitate the participation of postgraduate students and young scientists, the workshop will begin with a talk on the fundamentals of XRD, followed by an introduction to pharmaceutical materials science. The topics to be covered in the workshop are:

  • Instrumental and software advances
  • Direct analysis of pharmaceutical dosage forms
  • Quantitative phase analyses
  • Use of XRD in the characterization of nanomaterials and amorphous phases
  • Effective use of databases
  • Applications of high intensity X-radiation
  • Regulatory applications of XRD (including QbD)

Workshop Instructors:
Dr. Raj Suryanarayanan, Workshop Chair, University of Minnesota, U.S.A.
Dr. Detlef Beckers, PANalytical, The Netherlands
Dr. Cyrus Crowder, ICDD, Newtown Square, PA, U.S.A.
Dr. Tim Fawcett, ICDD, Newtown Square, PA, U.S.A.
Dr. Geert Vanhoyland, Bruker-AXS GmbH, Germany

Tuesday, 5 May - 8.30-17.20

Type Title of Paper Speaker & Affiliation
  WELCOMING REMARKS & INTRODUCTIONS Cyrus Crowder, ICDD, Newtown Square, PA, U.S.A.
Morning Organic Crystal Structure Prediction
Session Chair: Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
Invited COMPUTED CRYSTAL ENERGY LANDSCAPES AS AN AID TO UNDERSTANDING POLYMORPHISM Sarah (Sally) L. Price, University College London, London, U.K.
Contributed POWDER DIFFRACTION AND CRYSTAL STRUCTURE PREDICTION: A TWO-WAY RELATIONSHIP Maryjane Tremayne, University of Birmingham, Birmingham, U.K.
  XRPD Structural Techniques (Acquisition and Use of XRPD Data, Indexing, Structure Determination, Rietveld Refinement)
Session Co-chairs: Dr. Ken Shankland, Reading University, Reading, U.K. and Dr. Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
Invited ADVANCES IN CRYSTAL STRUCTURE SOLUTION BY EXPO2008 Angela Altomare, IC-CNR, Bari, Italy
Contributed TRANSFORMATIONS AND CRYSTAL STRUCTURES OF A SUBSTITUED TRIAZINE AND ITS SALT FORMS: A VT-XRPD, SDPD AND CASTEP STUDY Julie Bardin, University of Strathclyde, Glasgow, Scotland, U.K.
Contributed SOLVING ORGANIC STRUCTURES FROM POWDER DATA AT LOW RESOLUTION USING CHARGE FLIPPING COMBINED WITH MAXIMUM ENTROPY TECHNIQUES Christopher Gilmore, University of Glasgow, Glasgow, Scotland, U.K.
Contributed A NEW HIGH PERFORMANCE HIGH-RESOLUTION POWDER DIFFRACTION SYSTEM AND ITS APPLICATIONS TO CRYSTAL STRUCTURE ANALYSIS Paul Ulrich Pennartz, Rigaku European Headquarters, Eschweiler, Germany
Afternoon Formulation, Product Development, Drug Delivery and Polymorph & Salt Screening
Session Chair: Dr. Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, U.S.A.
Invited SCREENING FOR SOLID-STATE TRANSFORMATIONS DURING SALT SELECTION Gregory Stephenson, Eli Lilly and Company, Indianapolis, IN, U.S.A.
Contributed ANALYSIS OF BLISTER PACKED TABLETS Detlef Beckers, PANalytical, Almelo, The Netherlands
Contributed MANY PATTERNS AND MANY METHODS: NEW METHODS UTILISING MULTIPLE ANALYSIS TECHNIQUES IN POLYMORPH AND SALT SCREENING SYSTEMS Gordon Barr, University of Glasgow, Glasgow, Scotland, U.K.
Contributed DETERMINATION OF THE EUTECTIC TEMPERATURE OF TREHALOSE-WATER BINARY SYSTEM BY X-RAY DIFFRACTOMETRY Prakash Sundaramurthi, University of Minnesota, Minneapolis, MN, U.S.A.
Contributed PARTICLE SIZE ANALYSIS BY TWO-DIMENSIONAL XRD Bob He, Bruker-AXS, Inc., Madison, WI, U.S.A.
Contributed MATERIAL IDENTIFICATION:
THE DESCRIPTIVE STATISTICS OF PHASE IDENTIFICATION		 Timothy Fawcett, ICDD, Newtown Square, PA, U.S.A.

Tuesday Evening (18.30-20.30)                     Poster Session
Title of Paper Speaker & Affiliation
QUANTITATIVE PHASE ANALYSIS OF ISOTIBOLONE IN TIBOLONE RAW MATERIAL USING THE SCARLETT-MADSEN METHOD Selma Gutierrez Antonio, Institute of Chemistry - UNESP, Araraquara, São Paulo, Brazil
STRUCTURE DETERMINATION OF A NEW POLYMORPH OF RACEMIC IBUPROFEN FROM LAB XRPD DATA Jean-Baptiste Arlin, University of Strathclyde, Glasgow, Scotland, U.K.
X-RAY SCATTERING STUDIES ON NANO CRYSTALLINE AND AMORPHOUS MATERIALS USING HIGH-ENERGY X-RAYS ON A LABORATORY SYSTEM Detlef Beckers, PANalytical, Almelo, The Netherlands
APPLICATION OF HIGH-THROUGHPUT CLUSTER ANALYSIS TO MULTIPLE DATA TYPE – COMBINING DATASETS Gordon Cunningham, University of Glasgow, Glasgow, Scotland, U.K.
METROLOGICAL ASSURANCE OF QUALITY CONTROL OF PHARMACEUTICAL PRODUCTION USING POWDER XRD METHODS Boris Kodess, VNIIMS, ICS&E, Moscow, Russia
CHARACTERIZATION OF PHARMACEUTICALS BY XRPD AND THERMAL ANALYSIS: BUPROPION HYDROCHLORIDE Elisabetta Maccaroni, Università dell'Insubria, Como, Italy
THE ROLE OF XRPD IN ACCELERATING PHARMACEUTICAL
PHASE IDENTIFICATION AND SELECTION		 A. E. McKeown, Merck & Co. Inc, Rahway, NJ, U.S.A.
STUDYING STRUCTURAL ASPECTS OF SALT HYDRATION BY VT-PXRD Gary Miller, University of Strathclyde, Glasgow, Scotland, U.K.
COMPARISON OF SPECIMEN PREPARATION TECHNIQUES FOR X-RAY POWDER DIFFRACTION DATA OF ALPHA TEGAFUR Fangling Needham, ICDD, Newtown Square, PA, U.S.A.
X-RAY POWDER DIFFRACTION IN QUANTIFYING POLYMORPHIC MIXTURES OF PHARMACEUTICAL SOLIDS: A CASE STUDY OF FAMOTIDINE Zoltán Német, Gedeon Richter Plc, Budapest, Hungary
CRYSTALLIZATION OF LYOPROTECTANT IN THE FROZEN SYSTEM AND ITS PHASE TRANSITION DURING DRYING Prakash Sundaramurthi, University of Minnesota, Minneapolis, MN, U.S.A.
CRYSTAL STRUCTURES OF PHARMACEUTICALLY ACCEPTABLE CARBAMAZEPINE COCRYSTALS FROM SYNCHOTRON DATA Ryan Taylor, University of Strathclyde, Glasgow, Scotland, U.K.

Wednesday, 6 May - 8.30 – 17.35
Morning Amorphous, Activated and Nanomaterials
Session Chair: Dr. Julien Giovannini, AstraZeneca, Nottingham, U.K. 
Type Title of Paper Speaker & Affiliation
Invited PHYSICAL STABILITY OF AMORPHOUS SOLID DISPERSIONS: XRPD AND COMPUTATIONAL STUDIES OF ‘MISCIBILITY’ Igor Ivanisevic, SSCI, a division of APTUIT Inc., West Lafayette, IN, U.S.A.
Invited CRYSTALLITE SIZES AND MICROSTRAINS DETERMINED BY RIETVELD REFINEMENT: APPLICATION TO MILLED LACTOSE Vincent Caron, Trinity College Dublin, Dublin, Ireland
Contributed XPRD, EXAFS, AND SAXS FOR CHARACTERIZATION OF NANOPARTICLES FOR PHARMACOLOGY Michael Boiko, Ioffe Physical-Technical Institute, Saint-Petersburg, Russia
Contributed CHARACTERISATION AND PREDICTION OF STABILITY OF AMORPHOUS MATERIALS DURING PHARMACEUTICAL DEVELOPMENT: PAIR-WISE DISTRIBUTION FUNCTION Helen Blade, AstraZeneca, Macclesfield, Cheshire, U.K.
Contributed DIFFRACTION, NON-CRYSTALLINITY, AND THE PDF DATABASE Cyrus Crowder, ICDD, Newtown Square, PA, U.S.A.
Contributed STUDYING AMORPHOUS PHARMACEUTICAL MATERIALS BY POWDER X-RAY DIFFRACTION AND OTHER SOLID-STATE TECHNIQUES Shawn Yin, Birstol-Myers Squibb, New Brunswick, NJ, U.S.A.
Contributed QUANTITATIVE ANALYSIS OF PHASES WITH PARTIAL OR NO KNOWN CRYSTAL STRUCTURE Geert Vanhoyland, Bruker AXS GmbH, Karlsruhe, Germany
Afternoon New Frontiers in XRD in Pharmaceutical R&D
Session Co-chairs: Dr. Cyrus Crowder, ICDD, Newtown Square, PA, U.S.A., and Dr. Harry Brittain, Center for Pharmaceutical Physics, Milford, NJ, U.S.A.
Invited TOWARD A RATIONALIZATION OF THE HYDRATION-DEHYDRATION MECHANISM OF SODIUM DICLOFENAC Christopher Frampton, SAFC Pharmorphix Ltd., Cambridge, Cambridgeshire, U.K.
Invited PROTEIN POWDER DIFFRACTION AT THE ESRF Jonathan Wright, ESRF, Grenoble cedex, France
Contributed NEW POSSIBILITIES FOR X-RAY DIFFRACTOMETRY Bernd Hasse, Incoatec GmbH, Geesthacht, Germany
  Complementary Techniques
Session Chair: Dr. Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, U.S.A.
Invited ENVIRONMENTAL ATOMIC FORCE AND CONFOCAL RAMAN MICROSCOPIES IN PHARMACEUTICAL SCIENCE Greg Haugstad, University of Minnesota, Minneapolis, MN, U.S.A.
Contributed APPLICATION OF X-RAY SPECTROMETRY AT X-RAY ABSORPTION EDGES FOR INVESTIGATION OF HUMAN ALBUMIN Konstantin Pogrebitsky, Ioffe Physical-Technical Institute, Saint-Petersburg, Russia


Thursday, 7 May - 8.30 – 12.00
Morning Patent and Regulatory Issues
Session Co-chairs: Dr. Peter Varlashkin, GlaxoSmithKline, Durham, NC, U.S.A., Dr. Fangling Needham, ICDD, Newtown Square, PA, U.S.A., and Dr. Philip G. Lake, GlaxoSmithKline, Leigh, U.K.
Type Title of Paper Speaker & Affiliation
Invited BUILDING A STRONG PATENT PORTFOLIO WITH COCRYSTALS AND DISORDERED SOLIDS – A LIFECYCLE MANAGEMENT APPROACH Eyal Barash, SSCI, a division of Aptuit Inc., West Lafayette, IN, U.S.A.
Round Robin Results from PPXRD-7
Session Chair: Dr. Fangling Needham, ICDD, Newtown Square, PA, U.S.A.
Title of Paper Speaker & Affiliation
ROUND ROBIN for PHARMACEUTICAL COMPOUNDS Fangling Needham, Cyrus Crowder, Timothy Fawcett, ICDD, Newtown Square, PA, U.S.A.
        Q&A/Closing Remarks

 

Contact:
Leah Mooney, Education Coordinator
International Centre for Diffraction Data
+610-325-9814
E-mail: ppxrd@icdd.com
Web: www.icdd.com/ppxrd

Who Should Attend PPXRD?
Pharmaceutical Research and Development Scientists and Academia interested in:

Organizing Committee
Dr. Cyrus Crowder, Chair, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
Dr. Harry G. Brittain, Center for Pharmaceutical Physics, Milford, NJ, U.S.A.
Dr. Julien Giovannini, AstraZeneca, Nottingham, U.K. 
Dr. Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
Terry Maguire, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Leah Mooney, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Fangling Needham, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Kenneth Shankland, Reading University, Reading, U.K.
Dr. Gregory A. Stephenson, Eli Lilly and Company, Indianapolis, IN, U.S.A.
Dr. Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, U.S.A.
Dr. Peter G. Varlashkin, GlaxoSmithKline, Durham, NC, U.S.A.
Dr. Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, U.S.A.

 

Stay Informed
For the latest symposium information:
Visit www.icdd.com/ppxrd or Phone: +610-325-9814
Fax: +610-325-9823
E-mail: ppxrd@icdd.com

To receive a brochure, e-mail your mailing address to ppxrd@icdd.com